Since then, Kythera Biopharmaceuticals Inc has gained 235.69% as of 09/30/2016's recent price of $74.69. If you would have followed this Leerink Swann 's recommendation on KYTH, you would have gained 235.68% of your investment in 1425 days.

Leerink Swann Equity Research provides unique perspectives and agenda-setting healthcare recommendations for investors. Supported by industry-based intelligence and thorough market examination, our proprietary research enables our clients to make well-informed healthcare investment decisions.
Our investment perspectives are driven by proprietary insights from MEDACorp. MEDACorp's more than 25,000 network professionals work with new and/or development-stage pharmaceuticals, medical devices and biotherapeutics on a daily basis. MEDACorp's extensive knowledge of products and research enables Leerink Swann to provide growth-focused clients an expertise earned through experience.

GainersToday is a Financial Web Site that provides to investors and traders, stock market recommendations, rankings and financial news. GainersToday keeps track of more than 20,000 recommendations given by more than 200 Research Companies.

At GainersToday smart investors can instantly find and compare thousands of
stocks recommendations. You can see past performance of Research Companies,
Accuracy, Percentage Gains.

You can add alerts by stock or by Research Company when a new stock
recommendation is released.